The phase 3 trial enrolled 1033 patients who had not received prior chemotherapy for mCRPC and had evidence of disease progression despite androgen deprivation therapy.

The FDA has granted Orphan Drug designation to NS-229 for the treatment of eosinophilic granulomatosis with polyangiitis.

Rituximab may be an effective therapeutic option in the management of severe necrotizing scleritis associated with AAV.

The FDA approval draws on a phase 3 trial of Akeega, called MAGNITUDE, which showed that the addition of niraparib to Zytiga plus prednisone or prednisolone significantly improved radiographic ...

The CHMP recommendation follows a phase 3 trial of Akeega, called MAGNITUDE, which revealed that the addition of niraparib to Zytiga plus prednisone or prednisolone significantly improved ...

Our results support the hypothesis that a low initial dose of prednisone is sufficient to control PMR in the majority of patients. They also suggest that 0.20 mg per kg weight could be the ...

Prednisone, in combination with azathioprine, is the preferred initial treatment because of a lower frequency of side effects (Rating, II). Conventional treatment regimens should be continued in ...

A prednisone taper gradually reduces your corticosteroid dose over days, weeks, or months to prevent prednisone withdrawal. Stopping prednisone abruptly can lead to adrenal insufficiency, which causes ...

If you’re living with ulcerative colitis, testing may help identify which foods bother you, so that you can cut them out of your diet. Ulcerative colitis (UC) cannot cause a food allergy, but ...

Short-term oral prednisolone was successfully used in the treatment of four patients with chronic erosive gastritis which had failed to respond to conventional therapies. Symptomatic improvement ...